Joseph  C. Wu

Joseph C. Wu

Cardiologist

Bio:   Joseph C. Wu, MD, PhD is Director of the Stanford Cardiovascular Institute (http://cvi.stanford.edu/) and the Simon H. Stertzer, MD, Professor of Medicine and Radiology. Dr. Wu received his medical degree from Yale. He completed his medicine internship, residency and cardiology fellowship training at UCLA followed by a PhD (Molecular & Medical Pharmacology) in the UCLA STAR program. His clinical activities involve adult congenital heart disease and cardiovascular imaging.

His lab works on biological mechanisms of patient-specific and disease-specific induced pluripotent stem cells (iPSCs). The main goals are to (i) understand cardiovascular disease mechanisms, (ii) accelerate drug discovery, (iii) develop “clinical trial in a dish” concept, and (iv) implement precision medicine for prevention and treatment of cardiovascular patients. His lab uses a combination of genomics, stem cells, cellular & molecular biology, physiological testing, and molecular imaging technologies to better understand molecular and pathological processes. Dr. Wu has published >400 manuscripts with H-index of 94 on Google scholar. Among his trainees, >25 of them are principal investigators in the US or abroad (http://med.stanford.edu/wulab.html).

Dr. Wu has received numerous awards, including National Institutes of Health (NIH) Director’s New Innovator Award, NIH Roadmap Transformative Award, American Heart Association (AHA) Innovative Research Award, Presidential Early Career Award for Scientists and Engineers (PECASE) given out by President Obama, AHA Established Investigator Award, Burroughs Wellcome Foundation Innovation in Regulatory Science Award, AHA Merit Award, and AHA Distinguished Scientist Award. Dr. Wu serves on the Scientific Advisory Board for the Keystone Symposia, FDA Cellular, Tissue, and Gene Therapies Advisory Committee, AHA National Board of Directors, Chair of the AHA Basic Cardiovascular Science Council, and Chair of the AHA National Research Committee.

Dr. Wu is an elected member of American Society of Clinical Investigators (ASCI), Association of University Cardiologists (AUC), American Institute for Medical and Biological Engineering (AIMBE), American Association of Physicians (AAP), American Association for the Advancement of Science (AAAS), and National Academy of Medicine (NAM).

General Cardiology at Boswell Building

  • 300 Pasteur Drive
  • 2nd Floor, Room A260
  • Stanford , CA 94305
  • Phone: 650-725-5909
More Clinic Information » Getting Here » Make An Appointment

Professional Education

  • Fellowship, UCLA Medical Center, Cardiovascular Medicine (2004)
  • PhD, UCLA, Molecular & Medical Pharmacology (2004)
  • MD, Yale University School of Medicine, Medicine (1997)
  • BS, UCLA, Biology (1993)

Honors & Awards

  • Council Member, American Society Clinical Investigation (2014-2017)
  • Distinguished Investigator Award, Academy of Radiology Research (2014)
  • Distinguished Scientist Award, American Heart Association (2018)
  • Elected, American Association for the Advancement of Science (2019)
  • Elected, American Institute for Medical and Biological Engineering (2018)
  • Elected, American Society Clinical Investigation (ASCI) (2012)
  • Elected, Association of American Physicians (AAP) (2015)
  • Elected, Association of University Cardiologists (AUC) (2013)
  • Elected, National Academy of Medicine (2019)
  • Established Investigator Award, American Heart Association (2013)
  • Highly Cited Researcher (Top 1% in Web of Science), Clarivate Analytics (2108 & 2019)
  • Joseph A. Vita Award, American Heart Association (2015)
  • Merit Award, American Heart Association (2017)
  • NIH Director's New Innovator Award, National Institutes of Health (2008-2013)
  • NIH Roadmap Transformative Award, National Institutes of Health (2009-2014)
  • Presidential Early Career Award for Scientists and Engineers (PECASE), White House Office of Technology (2010)

Administrative Appointments

  • Director, Stanford Cardiovascular Institute (2013 - Present)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.